STORM Therapeutics is Drug Discovery in United Kingdom that focus on developer business. Founded in 2015. They cover business area such as developer, small molecule inhibitor, RNA-modifying enzyme, cancer, disease, RNA modifying enzyme, these enzyme class, RNA methyltransferase, physician, RNA epigenetic target.
2015
( 9 years old in 2024 )
Developer
-
Babraham Research Campus
Moneta Building
Cambridge CB22 3AT
England, United Kingdom
Private
developersmall molecule inhibitorRNA-modifying enzymecancerdiseaseRNA modifying enzymethese enzyme classRNA methyltransferasephysicianRNA epigenetic target
* We use standard office opening hours in near STORM Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
STORM Therapeutics is Drug Discovery business from United Kingdom that founded in 2015 (9 years old in 2024), STORM Therapeutics business is focusing on Developer.
STORM Therapeutics headquarter office and corporate office address is located in Babraham Research Campus Moneta Building Cambridge CB22 3AT England, United Kingdom.
STORM Therapeutics was founded in United Kingdom.
In 2024, STORM Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with STORM Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
